These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 25857058

  • 1. [Erlotinib, sunitinib, and everolimus].
    Takahashi M.
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():409-13. PubMed ID: 25857058
    [No Abstract] [Full Text] [Related]

  • 2. Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors.
    Liakakos T, Roukos DH.
    Future Oncol; 2011 Sep; 7(9):1025-9. PubMed ID: 21919689
    [No Abstract] [Full Text] [Related]

  • 3. Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms.
    Crippa S, Partelli S, Boninsegna L, Falconi M.
    Ann Oncol; 2012 Jul; 23(7):1928. PubMed ID: 22753260
    [No Abstract] [Full Text] [Related]

  • 4. A shining light in the darkness for the treatment of pancreatic neuroendocrine tumors.
    Capdevila J, Tabernero J.
    Cancer Discov; 2011 Aug; 1(3):213-21. PubMed ID: 22586573
    [Abstract] [Full Text] [Related]

  • 5. Advances in pancreatic neuroendocrine tumor treatment.
    van der Veldt AA, Kleijn SA.
    N Engl J Med; 2011 May 12; 364(19):1873; author reply 1873-5. PubMed ID: 21561355
    [No Abstract] [Full Text] [Related]

  • 6. Promising advances in the treatment of malignant pancreatic endocrine tumors.
    Jensen RT, Delle Fave G.
    N Engl J Med; 2011 Feb 10; 364(6):564-5. PubMed ID: 21306243
    [No Abstract] [Full Text] [Related]

  • 7. New treatments of pancreatic neuroendocrine tumors: why using them? How to use them?
    Raymond E, Ruszniewski P.
    Target Oncol; 2012 Jun 10; 7(2):91-2. PubMed ID: 22669625
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Translational medicine: Cancer lessons from mice to humans.
    Tuveson D, Hanahan D.
    Nature; 2011 Mar 17; 471(7338):316-7. PubMed ID: 21412332
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
    Yoo C, Cho H, Song MJ, Hong SM, Kim KP, Chang HM, Chae H, Kim TW, Hong YS, Ryu MH, Kang YK, Kim SC, Ryoo BY.
    Cancer Chemother Pharmacol; 2017 Jan 17; 79(1):139-146. PubMed ID: 27942928
    [Abstract] [Full Text] [Related]

  • 14. Novel agents in gastroenteropancreatic neuroendocrine tumors.
    Stevenson R, Libutti SK, Saif MW.
    JOP; 2013 Mar 10; 14(2):152-4. PubMed ID: 23474560
    [Abstract] [Full Text] [Related]

  • 15. Three new drugs available to fight kidney cancer.
    Bankhead C.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1181-2. PubMed ID: 16954469
    [No Abstract] [Full Text] [Related]

  • 16. Advances in the treatment of pancreatic neuroendocrine tumours.
    Gao F, Visvardis EE, Sita-Lumsden A, Waxman J.
    QJM; 2012 Sep 06; 105(9):819-22. PubMed ID: 22383691
    [Abstract] [Full Text] [Related]

  • 17. Sunitinib-associated thrombotic microangiopathy: a significant risk.
    Buckley FD, Preston G, Meiklejohn DJ, Adamson D.
    Clin Oncol (R Coll Radiol); 2014 Aug 06; 26(8):515. PubMed ID: 24746506
    [No Abstract] [Full Text] [Related]

  • 18. [Targeted therapies, prognostic and predictive factors in endocrine oncology].
    Hescot S, Baudin E, Borson-Chazot F, Lombès M.
    Ann Endocrinol (Paris); 2013 Oct 06; 74 Suppl 1():S13-22. PubMed ID: 24356287
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States.
    Casciano R, Chulikavit M, Perrin A, Liu Z, Wang X, Garrison LP.
    J Med Econ; 2012 Oct 06; 15 Suppl 1():55-64. PubMed ID: 22881362
    [Abstract] [Full Text] [Related]

  • 20. Recent studies show promise for treating rare pancreatic tumors.
    Peres J.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):624-7. PubMed ID: 21474831
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.